Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Injuries | 10 | 2022 | 551 | 2.730 |
Why?
|
| Nerve Regeneration | 3 | 2022 | 42 | 2.170 |
Why?
|
| Genetic Therapy | 6 | 2017 | 291 | 1.910 |
Why?
|
| Gene Transfer Techniques | 5 | 2016 | 173 | 1.740 |
Why?
|
| Surface-Active Agents | 3 | 2017 | 57 | 1.270 |
Why?
|
| Polyethyleneimine | 5 | 2018 | 14 | 1.260 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 24 | 1.250 |
Why?
|
| Transfection | 5 | 2017 | 782 | 1.240 |
Why?
|
| Nanoparticles | 5 | 2022 | 254 | 1.090 |
Why?
|
| Biocompatible Materials | 3 | 2021 | 247 | 0.930 |
Why?
|
| Dielectric Spectroscopy | 1 | 2023 | 3 | 0.910 |
Why?
|
| Bevacizumab | 2 | 2020 | 34 | 0.890 |
Why?
|
| Polymers | 5 | 2022 | 244 | 0.860 |
Why?
|
| DNA | 2 | 2017 | 597 | 0.860 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2018 | 2083 | 0.820 |
Why?
|
| Spinal Cord | 4 | 2016 | 244 | 0.820 |
Why?
|
| Polyglycolic Acid | 8 | 2016 | 20 | 0.810 |
Why?
|
| Nanostructures | 2 | 2021 | 112 | 0.780 |
Why?
|
| Chitosan | 3 | 2021 | 11 | 0.760 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 64 | 0.760 |
Why?
|
| Lactic Acid | 7 | 2016 | 86 | 0.750 |
Why?
|
| Nucleic Acids | 2 | 2019 | 16 | 0.730 |
Why?
|
| Axons | 2 | 2021 | 139 | 0.720 |
Why?
|
| Glioma | 1 | 2020 | 140 | 0.710 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 219 | 0.690 |
Why?
|
| Neural Stem Cells | 6 | 2016 | 32 | 0.670 |
Why?
|
| Polyglactin 910 | 2 | 2018 | 8 | 0.670 |
Why?
|
| Rats | 18 | 2020 | 5300 | 0.650 |
Why?
|
| Myocytes, Cardiac | 4 | 2010 | 442 | 0.630 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 434 | 0.630 |
Why?
|
| Animals | 31 | 2021 | 20877 | 0.600 |
Why?
|
| Micelles | 2 | 2018 | 43 | 0.600 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2017 | 19 | 0.590 |
Why?
|
| Recovery of Function | 2 | 2022 | 506 | 0.590 |
Why?
|
| Cell Differentiation | 7 | 2023 | 1034 | 0.570 |
Why?
|
| Hyaluronic Acid | 2 | 2021 | 206 | 0.560 |
Why?
|
| Regeneration | 5 | 2008 | 105 | 0.470 |
Why?
|
| Embryonic Stem Cells | 3 | 2007 | 40 | 0.470 |
Why?
|
| Nanospheres | 2 | 2016 | 8 | 0.460 |
Why?
|
| Hepatocytes | 2 | 2006 | 205 | 0.460 |
Why?
|
| Cells, Cultured | 12 | 2017 | 2673 | 0.430 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 13 | 0.430 |
Why?
|
| Heterocyclic Compounds | 1 | 2012 | 24 | 0.430 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 126 | 0.410 |
Why?
|
| Adipose Tissue | 2 | 2010 | 221 | 0.400 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 1849 | 0.380 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 467 | 0.380 |
Why?
|
| Mice | 16 | 2016 | 8472 | 0.360 |
Why?
|
| Stromal Cells | 1 | 2009 | 113 | 0.330 |
Why?
|
| Keratinocytes | 2 | 2005 | 68 | 0.320 |
Why?
|
| Gene Silencing | 2 | 2019 | 137 | 0.310 |
Why?
|
| Cations | 2 | 2017 | 51 | 0.290 |
Why?
|
| Cell Survival | 5 | 2016 | 901 | 0.290 |
Why?
|
| Durapatite | 4 | 2020 | 33 | 0.280 |
Why?
|
| Fibrin | 2 | 2008 | 35 | 0.270 |
Why?
|
| Tissue Engineering | 5 | 2007 | 212 | 0.270 |
Why?
|
| Bone Regeneration | 2 | 2020 | 20 | 0.260 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1173 | 0.260 |
Why?
|
| Cell Transplantation | 1 | 2005 | 22 | 0.260 |
Why?
|
| Epidermis | 1 | 2005 | 42 | 0.250 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 95 | 0.250 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 951 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 111 | 0.240 |
Why?
|
| Gene Expression | 5 | 2016 | 770 | 0.240 |
Why?
|
| Suspensions | 1 | 2023 | 11 | 0.230 |
Why?
|
| Transgenes | 2 | 2016 | 92 | 0.220 |
Why?
|
| Erythropoietin | 2 | 2020 | 96 | 0.210 |
Why?
|
| Magnetics | 1 | 2022 | 52 | 0.210 |
Why?
|
| Drug Carriers | 3 | 2018 | 90 | 0.200 |
Why?
|
| Skin | 1 | 2005 | 451 | 0.200 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 1174 | 0.200 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2020 | 1 | 0.200 |
Why?
|
| Male | 10 | 2017 | 37281 | 0.190 |
Why?
|
| Gliosis | 1 | 2021 | 51 | 0.190 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 89 | 0.190 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 159 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2550 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 2 | 2016 | 164 | 0.190 |
Why?
|
| Hindlimb | 1 | 2020 | 38 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 63 | 0.190 |
Why?
|
| Genes, Reporter | 1 | 2020 | 191 | 0.190 |
Why?
|
| Cell Culture Techniques | 4 | 2010 | 189 | 0.190 |
Why?
|
| Astrocytes | 2 | 2021 | 270 | 0.180 |
Why?
|
| Endothelial Cells | 3 | 2020 | 384 | 0.180 |
Why?
|
| Hypoxia | 2 | 2011 | 169 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 63 | 0.180 |
Why?
|
| Bone and Bones | 1 | 2020 | 145 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2007 | 236 | 0.160 |
Why?
|
| Spinal Cord Regeneration | 1 | 2018 | 3 | 0.160 |
Why?
|
| Rolipram | 1 | 2018 | 9 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2020 | 219 | 0.160 |
Why?
|
| Bone Marrow Cells | 3 | 2010 | 217 | 0.160 |
Why?
|
| Apoptosis | 4 | 2015 | 1640 | 0.150 |
Why?
|
| Collagen | 1 | 2021 | 636 | 0.150 |
Why?
|
| Absorbable Implants | 2 | 2006 | 29 | 0.140 |
Why?
|
| Stem Cell Transplantation | 2 | 2007 | 58 | 0.140 |
Why?
|
| Plasmids | 1 | 2017 | 258 | 0.140 |
Why?
|
| Osteoblasts | 2 | 2007 | 99 | 0.140 |
Why?
|
| Polyesters | 3 | 2020 | 55 | 0.140 |
Why?
|
| Injections, Spinal | 1 | 2016 | 18 | 0.140 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 60 | 0.140 |
Why?
|
| Humans | 10 | 2023 | 68525 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2008 | 152 | 0.140 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 56 | 0.140 |
Why?
|
| Biological Transport | 1 | 2016 | 210 | 0.130 |
Why?
|
| Static Electricity | 1 | 2016 | 91 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 200 | 0.130 |
Why?
|
| Particle Size | 1 | 2016 | 201 | 0.130 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2015 | 27 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 196 | 0.130 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 88 | 0.130 |
Why?
|
| Luciferases | 1 | 2015 | 105 | 0.130 |
Why?
|
| Cell Death | 1 | 2016 | 329 | 0.130 |
Why?
|
| Chickens | 1 | 2016 | 232 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 317 | 0.130 |
Why?
|
| Myosin Heavy Chains | 3 | 2010 | 49 | 0.130 |
Why?
|
| Methylprednisolone | 1 | 2015 | 99 | 0.130 |
Why?
|
| Kidney | 3 | 2008 | 945 | 0.120 |
Why?
|
| Cholesterol | 1 | 2016 | 331 | 0.120 |
Why?
|
| Dacarbazine | 1 | 2014 | 32 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2008 | 294 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2017 | 7028 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 234 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 151 | 0.110 |
Why?
|
| Actins | 3 | 2009 | 249 | 0.110 |
Why?
|
| Motor Activity | 1 | 2016 | 621 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 62 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2008 | 43 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2222 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2010 | 489 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 710 | 0.100 |
Why?
|
| Fetal Tissue Transplantation | 2 | 2008 | 12 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 63 | 0.090 |
Why?
|
| Cell Shape | 2 | 2006 | 37 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 71 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2009 | 110 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 384 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2012 | 1293 | 0.080 |
Why?
|
| Cell Separation | 1 | 2009 | 132 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2009 | 167 | 0.080 |
Why?
|
| Glycolates | 1 | 2007 | 2 | 0.080 |
Why?
|
| Fetus | 1 | 2008 | 157 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 208 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 954 | 0.070 |
Why?
|
| Bone Substitutes | 1 | 2006 | 20 | 0.070 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 44 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2006 | 41 | 0.070 |
Why?
|
| Glutaral | 1 | 2006 | 41 | 0.070 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2006 | 21 | 0.070 |
Why?
|
| Cardiomyoplasty | 1 | 2005 | 1 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 149 | 0.070 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2008 | 532 | 0.070 |
Why?
|
| Gestational Age | 1 | 2007 | 389 | 0.070 |
Why?
|
| Skin Physiological Phenomena | 1 | 2005 | 13 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 121 | 0.070 |
Why?
|
| Microspheres | 1 | 2005 | 59 | 0.070 |
Why?
|
| Dermis | 1 | 2005 | 29 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 124 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2005 | 74 | 0.070 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2005 | 17 | 0.060 |
Why?
|
| Stem Cells | 1 | 2006 | 248 | 0.060 |
Why?
|
| Ceramics | 2 | 2020 | 23 | 0.060 |
Why?
|
| Porosity | 2 | 2020 | 63 | 0.060 |
Why?
|
| Laminin | 1 | 2005 | 62 | 0.060 |
Why?
|
| Ischemia | 1 | 2006 | 229 | 0.060 |
Why?
|
| Heart Valves | 1 | 2006 | 171 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1047 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2006 | 153 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2005 | 105 | 0.060 |
Why?
|
| Biodegradation, Environmental | 1 | 2004 | 92 | 0.060 |
Why?
|
| Models, Animal | 1 | 2004 | 252 | 0.060 |
Why?
|
| Wound Healing | 1 | 2005 | 260 | 0.060 |
Why?
|
| Magnetic Fields | 1 | 2022 | 21 | 0.050 |
Why?
|
| Electromagnetic Phenomena | 1 | 2022 | 25 | 0.050 |
Why?
|
| Cell Line | 3 | 2012 | 1752 | 0.050 |
Why?
|
| Locomotion | 1 | 2022 | 135 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2005 | 902 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2004 | 400 | 0.050 |
Why?
|
| Calcium Phosphates | 1 | 2020 | 13 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 807 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 31 | 0.050 |
Why?
|
| Dental Implants | 1 | 2020 | 39 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 120 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2010 | 147 | 0.040 |
Why?
|
| Osteocalcin | 2 | 2010 | 37 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 263 | 0.040 |
Why?
|
| Calcification, Physiologic | 2 | 2008 | 31 | 0.040 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2018 | 4 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2008 | 57 | 0.040 |
Why?
|
| Spinal Cord Compression | 1 | 2018 | 23 | 0.040 |
Why?
|
| Body Fluids | 2 | 2008 | 41 | 0.040 |
Why?
|
| Osteopontin | 2 | 2007 | 28 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2008 | 54 | 0.040 |
Why?
|
| Female | 6 | 2008 | 38015 | 0.030 |
Why?
|
| Dogs | 2 | 2006 | 490 | 0.030 |
Why?
|
| Neurons | 2 | 2012 | 881 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 92 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 35 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2010 | 111 | 0.020 |
Why?
|
| Shear Strength | 1 | 2010 | 15 | 0.020 |
Why?
|
| Silicon | 1 | 2010 | 20 | 0.020 |
Why?
|
| Troponin I | 1 | 2010 | 34 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 174 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2010 | 311 | 0.020 |
Why?
|
| Osteonectin | 1 | 2010 | 69 | 0.020 |
Why?
|
| Drug Implants | 1 | 2008 | 19 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 55 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 78 | 0.020 |
Why?
|
| Skull | 1 | 2008 | 63 | 0.020 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2007 | 1 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2008 | 112 | 0.020 |
Why?
|
| Uremia | 1 | 2007 | 10 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1039 | 0.020 |
Why?
|
| Omentum | 1 | 2007 | 18 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2007 | 71 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2007 | 89 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 572 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 47 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 175 | 0.020 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2007 | 43 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2007 | 103 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2006 | 90 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2007 | 238 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 22 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2006 | 29 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 179 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2010 | 718 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 48 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 117 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2006 | 58 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2007 | 155 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 160 | 0.020 |
Why?
|
| Surface Properties | 1 | 2006 | 363 | 0.020 |
Why?
|
| Epithelium | 1 | 2005 | 172 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2007 | 523 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2007 | 714 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 176 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2006 | 324 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 317 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2006 | 222 | 0.020 |
Why?
|
| Swine | 1 | 2006 | 672 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 946 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 742 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2007 | 458 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1037 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 929 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 2331 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 2790 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.010 |
Why?
|